Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

If you’ve turned down a chance to go out with family or friends or cut down a favorite activity because you might fall, ...

Andrew Dudum, CEO of Hims & Hers Health Inc. (NYSE:HIMS), recently sold a significant portion of his holdings in the company.

Sanofi’s (SNY) said FDA lifted a hold on a trial to test over-the-counter use of its Eli-Lilly (LLY)-partnered erectile ...